SNP-Based Linkage Mapping for Validation of QTLs for Resistance to Ascochyta Blight in Lentil.

Lentil (Lens culinaris Medik.) is a self-pollinating, diploid, annual, cool-season, meals legume crop that’s cultivated all through the world. Ascochyta blight (AB), attributable to Ascochyta lentis Vassilievsky, is an economically necessary and widespread illness of lentil. Improvement of cultivars with excessive ranges of sturdy resistance supplies an environmentally acceptable and economically possible methodology for AB management.

An in depth understanding of the genetic foundation of AB resistance is therefore extremely fascinating, with a purpose to get hold of perception into the quantity and affect of resistance genes. Genetic linkage maps primarily based on single nucleotide polymorphisms (SNP) and easy sequence repeat (SSR) markers have been developed from three recombinant inbred line (RIL) populations. The IH × NF map contained 460 loci throughout 1461.6 cM, whereas the IH × DIG map contained 329 loci throughout 1302.5 cM and the third map, NF × DIG contained 330 loci throughout 1914.1 cM.

Information from these maps had been mixed with a map from a beforehand revealed examine via use of bridging markers to generate a consensus linkage map containing 689 loci distributed throughout seven linkage teams (LGs), with a cumulative size of 2429.61 cM at a mean density of 1 marker per 3.5 cM. Trait dissection of AB resistance was carried out for the RIL populations, figuring out totals of two and three quantitative trait loci (QTLs) explaining 52 and 69% of phenotypic variation for resistance to an infection within the IH × DIG and IH × NF populations, respectively. Presence of widespread markers within the neighborhood of the AB_IH1- and AB_IH2.1/AB_IH2.2-containing areas on each maps helps the inference {that a} widespread genomic area is chargeable for conferring resistance and is related to the resistant guardian, Indianhead. The third QTL was derived from Northfield. Analysis of markers related to AB resistance throughout a various lentil germplasm panel revealed that the identification of alleles related to AB_IH1 predicted the phenotypic responses with excessive ranges of accuracy (~86%), and due to this fact have the potential to be broadly adopted in lentil breeding applications.

The provision of RIL-based maps, a consensus map, and validated markers linked to AB resistance present necessary assets for lentil enchancment.

Comparative Agronomic Efficiency and Response to Fusarium wilt of Lens culinaris × L. orientalis and L. culinaris × L. ervoides derivatives.

The event of transgressive phenotype within the segregating populations has been imagined to contribute to area of interest divergence of hybrid lineages, which happens most steadily at bigger genetic distances. Wild Lens species are thought of to be extra resistant in opposition to main biotic and abiotic stresses than that of the cultivated species. Within the current examine, we assessed the comparative agronomic efficiency of lentil (Lens culinaris subsp. culinaris) inter-sub-specific (L. culinaris subsp. orientalis) and interspecific (L. ervoides) derivatives, additionally mentioned its possible foundation of incidence.
The F3, F4, and F5 inter sub-specific and interspecific populations of ILL8006 × ILWL62 and ILL10829 × ILWL30, respectively revealed a considerable vary of variation for majority of agro-morphological traits as mirrored by the vary, imply and coefficient of variation. A excessive degree of fruitful heterosis was additionally noticed in F3 and F4 progeny for necessary traits of curiosity. Phenotypic coefficient of variation (PCV) was increased in magnitude than genotypic coefficient of variation (GCV) in all generations for a number of quantitative characters. The outcomes confirmed excessive heritability estimates for majority of traits along with low to excessive genetic advance in F3 and F4 generations. Additional, F5 progeny of ILL10829 × ILWL30, manifested resistant illness response for fifteen recombinant inbred strains (RILs) in opposition.
The multilocation agronomic analysis of each crosses confirmed higher outcomes for earliness, fascinating seed yield and Fusarium wilt resistance underneath two agro-ecological areas of north-western India.
These higher performing recombinants of ILL8006 × ILWL62 and ILL10829 × ILWL30 might be superior for additional genetic enchancment and growing excessive yielding illness resistant cultivars of lentil.
 SNP-Based Linkage Mapping for Validation of QTLs for Resistance to Ascochyta Blight in Lentil.

The Results of Lentivirus-mediated shRNA Interference Concentrating on Mcl-1 on Progress of NK/T-cell Lymphoma.

Myeloid leukemia-1 (Mcl-1) gene has been reported as an necessary consider varied varieties of most cancers, however little analysis was processed on pure killer (NK)/T-cell lymphoma, a form of a extremely aggressive illness with a poor prognosis. Right here we investigated the expression of Mcl-1 in seven lymphoma cell strains and its potential function as a molecular drug goal for NK/T-cell lymphoma remedy by utilizing lentivirus-mediated shRNA interference focusing on Mcl-1. In our examine, the expression of Mcl-1 in numerous lymphoma cell strains had been evaluated firstly, after that lenti-shMcl-1 was constructed and transduced into NK/T-cell lymphoma cell line SNK-6 which had a excessive degree expression of Mcl-1.
Methylthiazolete-Trazolium (MTT) assay and circulate cytometry (FCA) had been employed to detect the standing of proliferation and apoptosis after an infection. Lastly we investigated the consequences of chemotherapy agent vincristine (VCR) mixture with lenti-shMcl-1 by MTT and FCA assay. The outcomes confirmed that Mcl-1 gene expressed in all seven lymphoma cell strains at totally different ranges. Recombinant lentiviruses might infect SNK-6 cells successfully. Mcl-1 expression degree was remarkably down-regulated after an infection with lenti-shMcl-1. The expansion of SNK-6 cells was inhibited considerably via apoptosis pathway.

Ready-to-use BSA Standard Solution Set (8 different concentrations)

PC0003 8x 1 mL Ask for price

Human Glucose concentration-Glucose concentration- ELISA Kit

QY-E05365 96T
EUR 400

Lentivirus Concentrator

LV-CONC one kit
EUR 276.5
Description: lentivirus concentration kit

Gas concentration agent

nBIONIX-A07 20
EUR 138

ETHANOL, 70% CONCENTRATION

IB15727 10L
EUR 210.13
Description: BOX W/SPIGOT (HAZ)

ddATP - high concentration

NU-271L 5 x 10µl
EUR 110.98

ddATP - high concentration

NU-271S 10µl
EUR 39.24

ddCTP - high concentration

NU-272L 5 x 10µl
EUR 110.98

ddCTP - high concentration

NU-272S 10µl
EUR 39.24

ddGTP - high concentration

NU-273L 5 x 10µl
EUR 110.98

ddGTP - high concentration

NU-273S 10µl
EUR 39.24

ddTTP - high concentration

NU-274L 5 x 10µl
EUR 110.98

ddTTP - high concentration

NU-274S 10µl
EUR 39.24

pSET152- Low concentration

PVT11339 2 ug
EUR 444

pSET152- high concentration

PVT11338 2 ug
EUR 444

Denhardt's solution, 100x Concentrate

D0062 25ml
EUR 82.97

Wash Solution Concentrate (50X)

WSC999 1000 ml
EUR 79.73

TEV Protease (High Concentration)

LE-002L 100000Units
EUR 3985.48

TEV Protease (High Concentration)

LE-002S 10000Units
EUR 522.55

MS BASAL SALT CONCENTRATION (20x)

M576 1000ML
EUR 25.31

Universal Virus Concentration Kit

C2901L For 3 L Ask for price

Universal Virus Concentration Kit

C2901M For 600 mL Ask for price

Universal Virus Concentration Kit

C2901S For 150mL Ask for price

PE Streptavidin (High Concentration)

GT17634 500 µg Ask for price

Washing Solution Concentrate (10X )

SD6001 1000 mL / Bottle Ask for price

Wash Solution 10X Concentrate (TBS)

SD2004
  • Ask for price
  • Ask for price
  • 50 mL
  • 2500 mL

APC Streptavidin (High Concentration)

GT17633 500 µg Ask for price

BD High Concentration Laminin - EACH

354259 EACH
EUR 849.15

Minimal Inhibitory Concentration Kit

K195-2500 each
EUR 836.4

Minimal Inhibitory Concentration Kit

K195-500 each
EUR 574.8

AvaI -HC unit: 330, High Concentration

YRAVA1-HC 1 vial Ask for price

SacI -HC unit: 1500, High Concentration

YRSAC1-HC 1 vial Ask for price

Biotin-11-UTP - high concentration

NU-821-BIOX-HC 30µl
EUR 1438.95

pRK2013- 1 (Low concentration) Plasmid

PVT5705 2 ug
EUR 390

T7 RNA Polymerase (High Concentration)

R7013L 500 KU Ask for price

T7 RNA Polymerase (High Concentration)

R7013M 100 KU Ask for price

T7 RNA Polymerase (High Concentration)

R7013S 25 KU Ask for price

EF1a-(Red-Luciferase) Lentivirus (Zeocin), Concentrated Lentivirus

LVP1304-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Zeocin selection.

X-Gal Solution, 40 mg/ml concentrate

X0321-005 5X1ml
EUR 45

X-Gal Solution, 40 mg/ml concentrate

X0321-020 20ml
EUR 70

RNA Clean-Up and Concentration Kit

23600 50 Preps
EUR 161.4

RNA Clean-Up and Concentration Kit

23640 4 Preps
EUR 12

RNA Clean-Up and Concentration Kit

43200 100 Preps
EUR 311.4

Biotin-11-dATP - high concentration

NU-1175-BIOX-HC 20 µL
EUR 603.29

Biotin-11-dCTP - high concentration

NU-809-BIOX-HC 500 µL
EUR 470.99

pRK2013- 2 (High concentration) Plasmid

PVT5706 2 ug
EUR 390

High Concentration Acid Surrogate - 1ML

CLP90-75SA 1ML
EUR 259.2

Kpn I -HC unit: 5000, High Concentration

YRKPN1-HC 1 vial Ask for price

Msp I -HC unit: 1400, High Concentration

YRMSP1-HC 1 vial Ask for price

Nco I -HC unit: 400, High Concentration

YRNCO1-HC 1 vial Ask for price

Pst I -HC unit: 12000, High Concentration

YRPST1-HC 1 vial Ask for price

Pvu II -HC unit: 2000, High Concentration

YRPVU2-HC 1 vial Ask for price

Rsa I -HC unit: 800, High Concentration

YRRSA1-HC 1 vial Ask for price

Sal I -HC unit: 2200, High Concentration

YRSAL1-HC 1 vial Ask for price

Sma I -HC unit: 1500, High Concentration

YRSMA1-HC 1 vial Ask for price

Taq I -HC unit: 410, High Concentration

YRTAQ1-HC 1 vial Ask for price

Xba I -HC unit: 3000, High Concentration

YRXBA1-HC 1 vial Ask for price

Xho I -HC unit: 5000, High Concentration

YRXHO1-HC 1 vial Ask for price

EF1a-(Red-Luciferase) Lentivirus (Neomycin), Concentrated Lentivirus

LVP1234-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Neomycin selection.

Dra I-HC unit: 3500, High Concentration

YRDRA1-HC 1 vial Ask for price

EcoR I -HC unit: 12000, High Concentration

YRECOR1-HC 1 vial Ask for price

Concentrating Solution for Sirius Red Total Collagen Detection Other

90626 50 ml
EUR 14
Description: Concentrating Solution for Sirius Red Total Collagen Detection Kit

Oligo Clean-Up and Concentration Kit

34100 50 Preps
EUR 107.4

Sperm Concentration Rapid Test Cassette

OSC-902H 1 Test
EUR 1.2

Chloride Std Solution Concentrate - 100ML

5000900C 100ML
EUR 203.85

BamH I-HC unit: 12000, High Concentration

YRBAMH1-HC 1 vial Ask for price

Bgl II-HC unit: 2500, High Concentration

YRBGL2-HC 1 vial Ask for price

EcoR V-HC unit: 2000, High Concentration

YRECOR5-HC 1 vial Ask for price

Hind III -HC unit: 12000, High Concentration

YRHIND3-HC 1 vial Ask for price

Hinf I-HC unit: 2000, High Concentration

YRHINF1-HC 1 vial Ask for price

EF1a-(Red-Luciferase) Lentivirus (Hygromycin), Concentrated Lentivirus

LVP1305-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Hygromycin selection.

EF1a-(Red-Luciferase) Lentivirus (Puromycin), Concentrated Lentivirus

LVP475-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Puromycin selection.

ViaCheck™ Concentration Control (0.5 × 106)

VC50N-20 20 mL
EUR 247.32
Description: HS Code : 38220000

ViaCheck Concentration Control 1 x 106

VC60N-20 20 ml
EUR 251.33
Description: ViaCheck Concentration Control 1 x 106 mimic the characteristics of live and dead cells in the trypan blue dye exclusion method and may be used to support validation and QC of image-based cell viability analyzers 

ViaCheck Concentration Control 4 x 106

VC70N-20 20 ml
EUR 367.48
Description: ViaCheck Concentration Control 4 x 106 mimic the characteristics of live and dead cells in the trypan blue dye exclusion method and may be used to support validation and QC of image-based cell viability analyzers 

ViaCheck Concentration Control 8 x 106

VC80N-20 20 ml
EUR 410.53
Description: ViaCheck Concentration Control 8 x 106 mimic the characteristics of live and dead cells in the trypan blue dye exclusion method and may be used to support validation and QC of image-based cell viability analyzers 

Presto™ Plasmid DNA Concentration Kit

PC0250 each
EUR 40

Presto™ Plasmid DNA Concentration Kit

PC0251 each
EUR 30

Presto™ Plasmid DNA Concentration Kit

PC0500 each
EUR 72.6

Presto™ Plasmid DNA Concentration Kit

PC0501 each
EUR 53.5

Presto™ Plasmid DNA Concentration Kit

PC1001 each
EUR 87

UPCK™ Urine Protein Concentration Kit

UPCK-10 10 preps
EUR 795

UPCK™ Urine Protein Concentration Kit

UPCK-25 25 preps
EUR 1143.6
Description: Urine Protein Enrichment Kit

UPCK™ Urine Protein Concentration Kit

UPCK-50 50 preps Ask for price

Cas9 Nuclease Protein (High Concentration)

K108 40 µg (250pmol) Volume: 25µL
EUR 80
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

Citrate concentrated buffer, 4% solution

GB4634 100ml
EUR 137.95

Citrate concentrated buffer, 4% solution

GB4634-100 100
EUR 45.2

Citrate concentrated buffer, 4% solution

GB4634-250 250
EUR 90.4

Citrate concentrated buffer, 4% solution

GB4634-500 500
EUR 150.7

BssH II-HC unit: 200, High Concentration

YRBSSH2-HC 1 vial Ask for price

BstE II-HC unit: 1300, High Concentration

YRBSTE2-HC 1 vial Ask for price

EcoT38 I -HC unit: 900, High Concentration

YRECOT38-HC 1 vial Ask for price

Hae III-HC unit: 3400, High Concentration

YRHAE3-HC 1 vial Ask for price

Hinc II-HC unit: 500, High Concentration

YRHINC2-HC 1 vial Ask for price

h LDOC1 (HA), Concentrated Lentivirus

LVP1132-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Premade lentivirus over-express human LDOC1 gene with N-term HA tag. It contains a RFP_Blasticidin fusion dual marker.

Aminoallyl-UTP-Cy3 - high concentration

NU-821-CY3-HC 10 µL
EUR 514.84

Aminoallyl-UTP-Cy5 - high concentration

NU-821-CY5-HC 10 µL
EUR 514.84

EF1a-(Red-Luciferase) Lentivirus (Blasticidin), Concentrated Lentivirus

LVP1232-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Blasticidin selection.

saCas9 Nuclease Protein (High Concentration)

K144 32.5 µg (250pmol) Volume: 25µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT).

h NEUROG2 Expression Lentivirus, concentrated

LVP658-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated lentivirus express human target: NEUROG2 (neurogenin 2), containing RFP-Blasticidin dual selection

m Plaur (CD87), Concentrated Lentivirus

LVP1400-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: lentivirus express mouse target: Plaur (CD87), containing a RFP-Blasticidin dual selection marker.

h IL1R1 (6His), Concentrated Lentivirus

LVP1133-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Premade lentivirus over-express human IL1R1 gene with C-term 6His tag. It contains a RFP_Blasticidin fusion dual marker.

BCA Protein concentration determination kit

BC016-500ml 500ml
EUR 110

ViaCheck™ Concentration Control 1 x 106

24627-20 20ml
EUR 248.4

ViaCheck™ Concentration Control 4 x 106

24628-20 20ml
EUR 376.92

ViaCheck™ Concentration Control 8 x 106

24629-20 20ml
EUR 426.6

GFP (CMV, No antibiotics) Lentivirus, Concentrated

LVP1334-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express GFP under CMV promoter (Does not contain any antibioic selection.)

RFP (CMV, No antibiotics) Lentivirus, Concentrated

LVP1336-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express GFP under CMV promoter (Does not contain any antibioic selection.)

mkate (CMV, Puro), Concentrated Lentivirus

LVP1507-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: mKate expression lentivirus under suCMV promoter, carrying Puromycin selection

Cas9 Null Mutant Protein (High Concentration)

K140 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type Cas9 (D10A and H840A). Such a Cas9 protein retains its ability to bind to genomic DNA through gRNA:genomic DNA base pairing, however, unlike Cas9 Nuclease and Cas9 Nickase, where permanent gene disruption can be achieved, the Cas9 Null Mutant does not introduce any genome modifications. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

OXYMETER O2 concentration measurement (0-25%)

8080 1 Piece Ask for price

High Concentration Matrigel (with Phenol Red)

M8380
  • Ask for price
  • Ask for price
  • 5 mL
  • 10 mL

GFP (EF1a, No antibiotics) Lentivirus, Concentrated

LVP1335-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express GFP under EF1a promoter (Does not contain any antibioic selection.)

RFP (EF1a, No antibiotics) Lentivirus, Concentrated

LVP1337-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express GFP under EF1a promoter (Does not contain any antibioic selection.)

BFP-Histone2B, Concentrated Lentivirus

LVP1491-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus expressing (BFP-human Histone 2B) fusion contruct under suCMV promoter without any antibiotic selection.

Mito-GFP (Puro), Concentrated Lentivirus

LVP893-G-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. GFP fluorescent signal targeted in Mitochondria. It contains the Puromycin selection marker.

Cas9 Nuclease NLS Protein (High Concentration)

K130 40 µg (250pmol) Volume: 25µL
EUR 80
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

Cas9 Nickase D10A Protein (High Concentration)

K132 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;;To counteract off-target mutagenic effects of this system, the Cas9 Nickase D10A was developed with a D10A mutation in its RuvC1 nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single-stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

dNTP SET, Concentration: 100mM, 4x1ml set of dNTP consisting 4 separate tubes (4x1ml) each with 100mM concentration of dATP, dGTP, dCTP, and dTTP.

2013SET each
EUR 361.42

Myoglobin Concentration ELISA Quantitation Kit

GWB-E1E945 ELISA_Kits Ask for price

DsRNA-unmodified Standard (High Concentration)

DD3413-C1 50 μL Ask for price

ProteoSpin™ Urine Protein Concentration Kit

17400 25 Preps
EUR 171

Cas9 Nickase H840A Protein (High Concentration)

K136 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;;To improve the off-target mutagenic effects of this system, the Cas9 Nickase H840A Protein was developed with a H840A mutation in its HNH-like nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single-stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

saCas9 Null Mutant Protein (High Concentration)

K146 32.5 µg (250pmol) Volume: 25µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The saCas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type saCas9. Such a saCas9 protein retains its ability to bind to genomic DNA through sgRNA:genomic DNA base pairing, however, the saCas9 Null Mutant does not induce cleavage. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT).

mCherry (CMV, Puro), Concentrated Lentivirus

LVP1419-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: mCherry expression lentivirus under suCMV promoter, carrying Puromycin selection

mTomato (CMV, Puro), Concentrated Lentivirus

LVP1506-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: mTomato expression lentivirus under suCMV promoter, carrying Puromycin selection

fnCpf1 Nuclease NLS Protein (High Concentration)

K187 380 μg (2.5 nmol) Volume: 250µL
EUR 365
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases.;
  • Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
  • Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
  • Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
  • Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
    • fnCpf1 is from the bacteria Francisella novicida. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by fnCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).

asCpf1 Nuclease NLS Protein (High Concentration)

K188 380 μg (2.5 nmol) Volume: 250µL
EUR 365
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases. ;
  • Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
  • Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
  • Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
  • Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
    • asCpf1 is from the bacteria Acidaminococcus. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by asCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).

saCas9 Nuclease NLS Protein (High Concentration)

K189 32.5 µg (250pmol) Volume: 50µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

asCpf1 Nuclease NLS Protein (High Concentration)

K088 38 μg (250 pmol) Volume: 25µL
EUR 75
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases.;
  • Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
  • Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
  • Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
  • Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
    • asCpf1 is from the bacteria Acidaminococcus. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by asCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).

saCas9 Nuclease NLS Protein (High Concentration)

K089 6.5 µg (50pmol) Volume: 50µL
EUR 55
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

CARBOMETER CO2 concentration measurement (0-100%)

8081 1 Piece Ask for price

CARBOMETER CO2 concentration measurement (0-20%)

8081-20 1 Piece Ask for price

METHAMETER CH4 concentration measurement (0-100%)

8082 1 Piece Ask for price

20nm Colloidal Gold, Ultra-high Concentration

G5870 10 mL Ask for price

30nm Colloidal Gold, Ultra-high Concentration

G5871 10 mL Ask for price

40nm Colloidal Gold, Ultra-high Concentration

G5872 10 mL Ask for price

50nm Colloidal Gold, Ultra-high Concentration

G5873 10 mL Ask for price

60nm Colloidal Gold, Ultra-high Concentration

G5874 10 mL Ask for price

70nm Colloidal Gold, Ultra-high Concentration

G5875 10 mL Ask for price

80nm Colloidal Gold, Ultra-high Concentration

G5876 10 mL Ask for price

High Concentration Matrigel (without Phenol Red)

M8381
  • Ask for price
  • Ask for price
  • 5 mL
  • 10 mL

mCherry (EF1a, Puro), Concentrated Lentivirus

LVP1420-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: mCherry expression lentivirus under EF1a promoter, carrying Puromycin selection

RNA Clean-Up and Concentration 96-Well Kit

25100 192 Preps
EUR 479.4

h ACE2 (GFP-Puro) concentrated Lentivirus

LVP1310-GP-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus express human target: ACE2, containing a GFP-Puromycin dual selection marker.

h MFN2 (GFP-Puro) Concentrated Lentivirus

LVP1327-GP-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated lentivirus for human target: MFN2, containing a GFP-Puromycin dual selection marker.

h IDO1 (GFP-Puro), Concentrated Lentivirus

LVP302-GP-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated lentivirus expres a human human IDO1 with a GFP-Puromycin fusion marker.

h CD19 (GFP-Pueo), Concentrated Lentivirus

LVP1084-GP-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Over-expression lentivirus expressing human target: CD19 gene, carrying GFP-Puromycin dual selection

h ETV2 Expression, concentrated Lentivirus

LVP1369 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated expression lentivirus for human target: ETV2, containing a RFP-Blasticidin dual selection marker.

h MSLN Expression, Concentrated Lentivirus

LVP1378-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Over-expression lentivirus for human target: MSLN, containing a RFP-Blasticidin dual selection marker.

RFP-Actin fusion, Concentrated Lentivirus

LVP446-R-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made lentiviral particles expressing (RFP-human Actin) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

h YAP1 Expression, Concentrated Lentivirus

LVP478-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express human target: YAP1 (alternative name: YAP, YAP2, YAP65, YKI), containing a RFP-Blasticidin dual selection marker.

h BMP2 Expression, Concentrated Lentivirus

LVP481-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made express human target: BMP2 gene, carrying RFP-Blasticidin dual selection.

h BCL2 Expression, Concentrated lentivirus

LVP553-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made Lentivirus express human target: h BCL2, containing a RFP-Blasticidin dual selection marker.

h GRM2 Expression, Concentrated Lentivirus

LVP660-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made over-expression lentivirus for expressing human target: GRM2 (glutamate receptor, metabotropic 2), contains the RFP-Blasticidin dual selection marker.

h IL10 Expression, Concentrated Lentivirus

LVP767 1x107 IFU/ml x 200ul
EUR 455
Description: Concentrated lentivirus for expressing human target: h IL10 (interleukin 10), containing a RFP-Blasticidin dual selection marker.

h SOX9 Expression, Concentrated Lentivirus

LVP773-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made over-expression lentivirus for expressing human target: SOX9 (SRY (sex determining region Y)-box 9), [alternative names: CMD1; CMPD1; SRA1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_000346_3. It also contains a RFP-Blasticidin dual selection marker.

h Mafa Expression, Concentrated Lentivirus

LVP794-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express human target: h Mafa. It contains a RFP-Blasticidin dual selection marker.

h CD40 Expression, Concentrated Lentivirus

LVP888-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: expression lentivirus express human target: CD40 (CD40 molecule, TNF receptor superfamily member 5), containg a RFP-Blasticidin dual selection marker.

h DLL1 Expression, Concentrated Lentivirus

LVP907 1x107 IFU/ml x 200ul
EUR 455
Description: Pre-made lentivirus express human target: h DLL1. It contains a RFP-Blasticidin dual selection marker.

h CD47 Expression, Concentrated Lentivirus

LVP918-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated expression lentivirus for human target: CD47, containing a RFP-Blasticidin dual selection marker.

h TERT Expression, Concentrated Lentivirus

LVP105-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express human TERT gene with a Blasticidin-RFP fusion marker (Dual selection).

h CD19 Expression, Concentrated Lentivirus

LVP1084-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated lentivirus express human target: CD19 (human CD19 molecule). It contains a RFP-Blasticidin dual selection marker.

h EGFR Expression, Concentrated Lentivirus

LVP1142-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made over-expression lentivirus for human target: EGFR, containing a RFP-Blasticidin dual selection marker.

h CD8a Expression, Concentrated Lentivirus

LVP1151-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made over-expression lentivirus for human target: CD8a, containing a RFP-Blasticidin dual selection marker.

h NEK6 Expression, Concentrated Lentivirus

LVP1182-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made over-expression lentivirus for human target: NEK6, containing a RFP-Blasticidin dual selection marker.

h STM1 Expression, Concentrated Lentivirus

LVP1209-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Pre-made over-expression lentivirus for human target: STM1, containing a RFP-Blasticidin dual selection marker.

Cas9 Null Mutant NLS Protein (High Concentration)

K142 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type Cas9 (D10A and H840A). Such a Cas9 protein retains its ability to bind to genomic DNA through gRNA:genomic DNA base pairing, however, unlike Cas9 Nuclease and Cas9 Nickase, where permanent gene disruption can be achieved, the Cas9 Null Mutant does not introduce any genome modifications. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Null Mutant NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.
In any other case, lenti-shMcl-1 additionally revealed a big chemosensitizing impact together with vincristine. In a phrase, we demonstrated that lenti-shMcl-1 had a big anti-NK/T cell lymphoma impact and focusing on Mcl-1 remedy could possibly be a promising novel method in remedy of lymphoma.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *